Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash-to-Debt 0.02
ACHC's Cash-to-Debt is ranked lower than
96% of the 272 Companies
in the Global Medical Care industry.

( Industry Median: 0.25 vs. ACHC: 0.02 )
Ranked among companies with meaningful Cash-to-Debt only.
ACHC' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 0.02 Max: 0.49
Current: 0.02
0
0.49
Equity-to-Asset 0.39
ACHC's Equity-to-Asset is ranked lower than
67% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 0.47 vs. ACHC: 0.39 )
Ranked among companies with meaningful Equity-to-Asset only.
ACHC' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.22  Med: 0.39 Max: 0.56
Current: 0.39
0.22
0.56
Debt-to-Equity 1.31
ACHC's Debt-to-Equity is ranked lower than
79% of the 210 Companies
in the Global Medical Care industry.

( Industry Median: 0.62 vs. ACHC: 1.31 )
Ranked among companies with meaningful Debt-to-Equity only.
ACHC' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.63  Med: 1.31 Max: 3.05
Current: 1.31
0.63
3.05
Debt-to-EBITDA 6.27
ACHC's Debt-to-EBITDA is ranked lower than
80% of the 204 Companies
in the Global Medical Care industry.

( Industry Median: 2.72 vs. ACHC: 6.27 )
Ranked among companies with meaningful Debt-to-EBITDA only.
ACHC' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -8.12  Med: 5.91 Max: 6.71
Current: 6.27
-8.12
6.71
Interest Coverage 2.16
ACHC's Interest Coverage is ranked lower than
81% of the 222 Companies
in the Global Medical Care industry.

( Industry Median: 6.77 vs. ACHC: 2.16 )
Ranked among companies with meaningful Interest Coverage only.
ACHC' s Interest Coverage Range Over the Past 10 Years
Min: 2.1  Med: 2.98 Max: 9.7
Current: 2.16
2.1
9.7
Piotroski F-Score: 7
Altman Z-Score: 1.25
Beneish M-Score: -2.62
WACC vs ROIC
5.09%
5.29%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 13.58
ACHC's Operating Margin % is ranked higher than
71% of the 272 Companies
in the Global Medical Care industry.

( Industry Median: 6.68 vs. ACHC: 13.58 )
Ranked among companies with meaningful Operating Margin % only.
ACHC' s Operating Margin % Range Over the Past 10 Years
Min: -17.77  Med: 15.36 Max: 17.24
Current: 13.58
-17.77
17.24
Net Margin % 6.11
ACHC's Net Margin % is ranked higher than
62% of the 272 Companies
in the Global Medical Care industry.

( Industry Median: 3.98 vs. ACHC: 6.11 )
Ranked among companies with meaningful Net Margin % only.
ACHC' s Net Margin % Range Over the Past 10 Years
Min: -16.12  Med: 5.97 Max: 10
Current: 6.11
-16.12
10
ROE % 7.47
ACHC's ROE % is ranked lower than
54% of the 254 Companies
in the Global Medical Care industry.

( Industry Median: 8.45 vs. ACHC: 7.47 )
Ranked among companies with meaningful ROE % only.
ACHC' s ROE % Range Over the Past 10 Years
Min: -72.42  Med: 8.25 Max: 12.2
Current: 7.47
-72.42
12.2
ROA % 2.76
ACHC's ROA % is ranked lower than
53% of the 273 Companies
in the Global Medical Care industry.

( Industry Median: 3.54 vs. ACHC: 2.76 )
Ranked among companies with meaningful ROA % only.
ACHC' s ROA % Range Over the Past 10 Years
Min: -16.9  Med: 3.2 Max: 4.84
Current: 2.76
-16.9
4.84
ROC (Joel Greenblatt) % 13.25
ACHC's ROC (Joel Greenblatt) % is ranked lower than
53% of the 272 Companies
in the Global Medical Care industry.

( Industry Median: 15.26 vs. ACHC: 13.25 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
ACHC' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -76.52  Med: 20.4 Max: 36.41
Current: 13.25
-76.52
36.41
3-Year Revenue Growth Rate 32.10
ACHC's 3-Year Revenue Growth Rate is ranked higher than
95% of the 208 Companies
in the Global Medical Care industry.

( Industry Median: 7.10 vs. ACHC: 32.10 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
ACHC' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 16.3  Med: 33.85 Max: 59.1
Current: 32.1
16.3
59.1
3-Year EBITDA Growth Rate 30.50
ACHC's 3-Year EBITDA Growth Rate is ranked higher than
87% of the 182 Companies
in the Global Medical Care industry.

( Industry Median: 6.90 vs. ACHC: 30.50 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
ACHC' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 30.5  Med: 40.7 Max: 82.2
Current: 30.5
30.5
82.2
3-Year EPS without NRI Growth Rate -56.70
ACHC's 3-Year EPS without NRI Growth Rate is ranked lower than
97% of the 161 Companies
in the Global Medical Care industry.

( Industry Median: 7.30 vs. ACHC: -56.70 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
ACHC' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -56.7  Med: 31.3 Max: 45.7
Current: -56.7
-56.7
45.7
GuruFocus has detected 4 Warning Signs with Acadia Healthcare Co Inc ACHC.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» ACHC's 30-Y Financials

Financials (Next Earnings Date: 2018-02-23)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2017

ACHC Guru Trades in Q1 2017

Pioneer Investments 164,984 sh (New)
Paul Tudor Jones 10,663 sh (New)
Chuck Royce 100,026 sh (New)
Andreas Halvorsen 755,830 sh (New)
Joel Greenblatt 789,604 sh (+171.74%)
Steven Cohen 1,085,000 sh (+143.44%)
Vanguard Health Care Fund 3,698,655 sh (+2.49%)
Alan Fournier 600,000 sh (unchged)
Richard Snow 25,000 sh (unchged)
Manning & Napier Advisors, Inc 224,340 sh (-40.51%)
Alan Fournier 1,875,174 sh (-41.58%)
Jim Simons 275,200 sh (-71.64%)
» More
Q2 2017

ACHC Guru Trades in Q2 2017

Vanguard Health Care Fund 3,698,655 sh (unchged)
Richard Snow 25,000 sh (unchged)
Andreas Halvorsen Sold Out
Manning & Napier Advisors, Inc Sold Out
Jim Simons Sold Out
Pioneer Investments Sold Out
Paul Tudor Jones Sold Out
Chuck Royce 98,026 sh (-2.00%)
Alan Fournier 1,328,735 sh (-29.14%)
Steven Cohen 562,300 sh (-48.18%)
Joel Greenblatt 167,007 sh (-78.85%)
» More
Q3 2017

ACHC Guru Trades in Q3 2017

Ken Fisher 204,996 sh (New)
Alan Fournier 1,610,790 sh (+21.23%)
Vanguard Health Care Fund 3,698,655 sh (unchged)
Richard Snow 25,000 sh (unchged)
Chuck Royce 96,026 sh (-2.04%)
Joel Greenblatt 137,206 sh (-17.84%)
Steven Cohen 191,761 sh (-65.90%)
» More
Q4 2017

ACHC Guru Trades in Q4 2017

Chuck Royce 258,526 sh (+169.23%)
Vanguard Health Care Fund 4,601,355 sh (+24.41%)
Joel Greenblatt Sold Out
Steven Cohen Sold Out
Richard Snow Sold Out
Ken Fisher 202,100 sh (-1.41%)
Alan Fournier 1,283,514 sh (-20.32%)
» More
» Details

Insider Trades

Latest Guru Trades with ACHC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Vanguard Health Care Fund 2017-12-31 Add 24.41%0.06%$27.79 - $47.61 $ 36.325%4,601,355
Ken Fisher 2017-12-31 Reduce -1.41%$27.79 - $47.61 $ 36.325%202,100
Joel Greenblatt 2017-12-31 Sold Out 0.1%$27.79 - $47.61 $ 36.325%0
Ken Fisher 2017-09-30 New Buy0.01%$44.84 - $53 $ 36.32-26%204,996
Joel Greenblatt 2017-09-30 Reduce -17.84%0.02%$44.84 - $53 $ 36.32-26%137,206
Joel Greenblatt 2017-06-30 Reduce -78.85%0.35%$41.31 - $49.6 $ 36.32-18%167,007
Vanguard Health Care Fund 2017-03-31 Add 2.49%0.01%$32.89 - $45.53 $ 36.32-10%3,698,655
Joel Greenblatt 2017-03-31 Add 171.74%0.28%$32.89 - $45.53 $ 36.32-10%789,604
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 622110    SIC: 8062
Compare:JSE:LHC, XSGO:BANMED-SD, ASX:HSO, NYSE:AMN, JSE:NTC, XTER:RHK, NSE:APOLLOHOSP, NYSE:SEM, SAU:4002, ISX:MIKA, HKSE:01515, NYSE:THC, NAS:LPNT, NAS:AMED, BKK:BH-Q, SAU:4004, NYSE:CHE, OSTO:ATT, NAS:TVTY, NYSE:EVHC » details
Traded in other countries:7RA.Germany,
Headquarter Location:USA
Acadia Healthcare Company Inc operates mental healthcare facilities in the United States. It addresses behavioral abnormalities through psychiatric facilities, substance abuse facilities and residential treatment centers.

Acadia Healthcare Company Inc functions in the United States healthcare sector. It manages behavioral health primarily through the U.S segment, which represents the United States market. Additionally, it operates through the U.K market. The company's properties comprise of psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioral healthcare services across the United States and the United Kingdom.

Ratios

vs
industry
vs
history
PE Ratio 18.34
ACHC's PE Ratio is ranked higher than
78% of the 200 Companies
in the Global Medical Care industry.

( Industry Median: 27.77 vs. ACHC: 18.34 )
Ranked among companies with meaningful PE Ratio only.
ACHC' s PE Ratio Range Over the Past 10 Years
Min: 14.26  Med: 47.89 Max: 575.78
Current: 18.34
14.26
575.78
Forward PE Ratio 14.53
ACHC's Forward PE Ratio is ranked higher than
82% of the 57 Companies
in the Global Medical Care industry.

( Industry Median: 18.76 vs. ACHC: 14.53 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 18.34
ACHC's PE Ratio without NRI is ranked higher than
78% of the 199 Companies
in the Global Medical Care industry.

( Industry Median: 27.25 vs. ACHC: 18.34 )
Ranked among companies with meaningful PE Ratio without NRI only.
ACHC' s PE Ratio without NRI Range Over the Past 10 Years
Min: 14.26  Med: 47.76 Max: 575.78
Current: 18.34
14.26
575.78
Price-to-Owner-Earnings 23.62
ACHC's Price-to-Owner-Earnings is ranked higher than
59% of the 111 Companies
in the Global Medical Care industry.

( Industry Median: 24.82 vs. ACHC: 23.62 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
ACHC' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 18.36  Med: 37.73 Max: 76.97
Current: 23.62
18.36
76.97
PB Ratio 1.27
ACHC's PB Ratio is ranked higher than
81% of the 252 Companies
in the Global Medical Care industry.

( Industry Median: 2.52 vs. ACHC: 1.27 )
Ranked among companies with meaningful PB Ratio only.
ACHC' s PB Ratio Range Over the Past 10 Years
Min: 0.99  Med: 3.14 Max: 5.75
Current: 1.27
0.99
5.75
PS Ratio 1.13
ACHC's PS Ratio is ranked higher than
66% of the 262 Companies
in the Global Medical Care industry.

( Industry Median: 1.70 vs. ACHC: 1.13 )
Ranked among companies with meaningful PS Ratio only.
ACHC' s PS Ratio Range Over the Past 10 Years
Min: 0.7  Med: 2.23 Max: 3.74
Current: 1.13
0.7
3.74
Price-to-Free-Cash-Flow 36.99
ACHC's Price-to-Free-Cash-Flow is ranked lower than
66% of the 137 Companies
in the Global Medical Care industry.

( Industry Median: 22.88 vs. ACHC: 36.99 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
ACHC' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 28.75  Med: 56.31 Max: 382.86
Current: 36.99
28.75
382.86
Price-to-Operating-Cash-Flow 8.49
ACHC's Price-to-Operating-Cash-Flow is ranked higher than
78% of the 187 Companies
in the Global Medical Care industry.

( Industry Median: 14.54 vs. ACHC: 8.49 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
ACHC' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 6.6  Med: 26.71 Max: 47.87
Current: 8.49
6.6
47.87
EV-to-EBIT 16.70
ACHC's EV-to-EBIT is ranked higher than
69% of the 218 Companies
in the Global Medical Care industry.

( Industry Median: 21.25 vs. ACHC: 16.70 )
Ranked among companies with meaningful EV-to-EBIT only.
ACHC' s EV-to-EBIT Range Over the Past 10 Years
Min: -221.7  Med: 23.4 Max: 138.5
Current: 16.7
-221.7
138.5
EV-to-EBITDA 12.24
ACHC's EV-to-EBITDA is ranked higher than
66% of the 231 Companies
in the Global Medical Care industry.

( Industry Median: 14.53 vs. ACHC: 12.24 )
Ranked among companies with meaningful EV-to-EBITDA only.
ACHC' s EV-to-EBITDA Range Over the Past 10 Years
Min: -32.6  Med: 20.7 Max: 651.1
Current: 12.24
-32.6
651.1
EV-to-Revenue 2.27
ACHC's EV-to-Revenue is ranked lower than
51% of the 271 Companies
in the Global Medical Care industry.

( Industry Median: 2.11 vs. ACHC: 2.27 )
Ranked among companies with meaningful EV-to-Revenue only.
ACHC' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.8  Med: 3.6 Max: 5.7
Current: 2.27
1.8
5.7
Current Ratio 1.36
ACHC's Current Ratio is ranked higher than
54% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 1.30 vs. ACHC: 1.36 )
Ranked among companies with meaningful Current Ratio only.
ACHC' s Current Ratio Range Over the Past 10 Years
Min: 0.93  Med: 1.41 Max: 4.38
Current: 1.36
0.93
4.38
Quick Ratio 1.35
ACHC's Quick Ratio is ranked higher than
56% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 1.21 vs. ACHC: 1.35 )
Ranked among companies with meaningful Quick Ratio only.
ACHC' s Quick Ratio Range Over the Past 10 Years
Min: 0.93  Med: 1.41 Max: 4.38
Current: 1.35
0.93
4.38
Days Inventory 0.84
ACHC's Days Inventory is ranked higher than
95% of the 205 Companies
in the Global Medical Care industry.

( Industry Median: 17.60 vs. ACHC: 0.84 )
Ranked among companies with meaningful Days Inventory only.
ACHC' s Days Inventory Range Over the Past 10 Years
Min: 0.81  Med: 0.92 Max: 1.02
Current: 0.84
0.81
1.02
Days Sales Outstanding 38.35
ACHC's Days Sales Outstanding is ranked higher than
53% of the 229 Companies
in the Global Medical Care industry.

( Industry Median: 40.49 vs. ACHC: 38.35 )
Ranked among companies with meaningful Days Sales Outstanding only.
ACHC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 34.19  Med: 46.56 Max: 59.22
Current: 38.35
34.19
59.22
Days Payable 21.12
ACHC's Days Payable is ranked lower than
73% of the 168 Companies
in the Global Medical Care industry.

( Industry Median: 49.56 vs. ACHC: 21.12 )
Ranked among companies with meaningful Days Payable only.
ACHC' s Days Payable Range Over the Past 10 Years
Min: 17.61  Med: 27.69 Max: 31.62
Current: 21.12
17.61
31.62

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -20.10
ACHC's 3-Year Average Share Buyback Ratio is ranked lower than
84% of the 159 Companies
in the Global Medical Care industry.

( Industry Median: -2.30 vs. ACHC: -20.10 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
ACHC' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -41.6  Med: -21.35 Max: -12.3
Current: -20.1
-41.6
-12.3

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 1.74
ACHC's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
58% of the 106 Companies
in the Global Medical Care industry.

( Industry Median: 2.00 vs. ACHC: 1.74 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
ACHC' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 1.74  Med: 2.49 Max: 3.05
Current: 1.74
1.74
3.05
Price-to-Median-PS-Value 0.50
ACHC's Price-to-Median-PS-Value is ranked higher than
92% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 1.01 vs. ACHC: 0.50 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
ACHC' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.39  Med: 1.02 Max: 1.61
Current: 0.5
0.39
1.61
Earnings Yield (Greenblatt) % 5.99
ACHC's Earnings Yield (Greenblatt) % is ranked higher than
75% of the 273 Companies
in the Global Medical Care industry.

( Industry Median: 3.86 vs. ACHC: 5.99 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
ACHC' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -9.8  Med: 3.7 Max: 6.8
Current: 5.99
-9.8
6.8

More Statistics

Revenue (TTM) (Mil) $2,814.69
EPS (TTM) $ 1.98
Beta0.72
Short Percentage of Float30.08%
52-Week Range $26.92 - 54.34
Shares Outstanding (Mil)87.85

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 2,826 2,988 3,207
EBIT (Mil $) 437 459 509
EBITDA (Mil $) 591 625 688
EPS ($) 2.23 2.52 2.99
EPS without NRI ($) 2.23 2.52 2.99
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: 77
Positive ROAY
Positive CFROAY
Higher ROA yoyY
CFROA > ROAY
Lower Leverage yoyY
Higher Current Ratio yoyY
Less Shares Outstanding yoyN
Higher Gross Margin yoyY
Higher Asset Turnover yoyN

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}